TScan Therapeutics TCRX
NASDAQ TCRX
$0.20 -0.02 (-9.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Cash & Current Investments (2020 - 2026)

Updated

TScan Therapeutics' Cash & Current Investments came in at $100.2 million for Q2 2026, down 54.0% from $218.05 million a year earlier and down 21.8% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics' Cash & Current Investments was $152.41 million, down 47.5% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $290.11 million in FY2024 (+51.1%), $192.04 million in FY2023 (+60.0%), $120.03 million in FY2022 (-25.6%) and $161.41 million in FY2021 (+363.9%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q1 2023.
  • Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 9.7% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 363.9%), and the weakest in Q2 2026 (a decline of 54.0%).
  • Business Quant data shows TCRX's Cash & Current Investments at $128.06 million (Q1 2026), $152.41 million (Q4 2025) and $184.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 TScan Therapeutics 25.99 Mn -539.13 Mn - 100.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.20 Mn
Mar 31, 2026 128.06 Mn
Dec 31, 2025 152.41 Mn
Sep 30, 2025 184.45 Mn
Jun 30, 2025 218.05 Mn
Mar 31, 2025 251.69 Mn
Dec 31, 2024 290.11 Mn
Sep 30, 2024 271.12 Mn
Jun 30, 2024 297.68 Mn
Mar 31, 2024 162.78 Mn
Dec 31, 2023 192.04 Mn
Sep 30, 2023 215.42 Mn
Jun 30, 2023 208.84 Mn
Mar 31, 2023 95.61 Mn
Dec 31, 2022 120.03 Mn
Sep 30, 2022 137.31 Mn
Jun 30, 2022 125.60 Mn
Mar 31, 2022 140.84 Mn
Dec 31, 2021 161.41 Mn
Sep 30, 2021 182.31 Mn
API Access

TScan Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TCRX&period=max&api_key=YOUR_API_KEY